Русский
Analysis of the BsmI (rs1544410) polymorphism of the vitamin D receptor gene and the clinical effect of 25(OH)D level correction in a population of late postmenopausal women in Yekaterinburg
DOI: https://dx.doi.org/10.18565/therapy.2022.4.31-40
Izmozherova N.V., Popov A.A., Ryabinina A.V., Vikhareva А.A., Safianik E.A., Spevak A.V.
1) Ural State Medical University of the Ministry of Healthcare of Russia, Yekaterinburg; 2) Institute of High Temperature Electrochemistry of the Ural Branch of the Russian Academy of Sciences, Yekaterinburg
Objective: to determine the possible genetic contribution to the pleiotropic effects of vitamin D3 after correction of serum 25(OH)D insufficiency and deficiency by loading and maintenance doses of cholecalciferol in postmenopausal women.
Material and methods. During the period from October 2018 to March 2020, 100 late postmenopausal patients were performed: diagnosis of comorbid pathology, molecular genetic study of the BsmI (A>G) polymorphism of the VDR gene by PCR-RT, evaluation of serum 25(OH)D level by the ECLIA method, assessment of modified menopausal index (MMI), mental status (MMSE scale), and quality of life (SF-36 questionnaire). To correct the level of 25(OH)D in the blood serum, an aqueous solution of cholecalciferol (Aquadetrim) was used in standard doses recommended by the Russian Association of Endocrinologists.
Results. The frequency distribution of the BsmI polymorphic marker genotypes of the VDR gene was 13, 47, and 40% for minor homozygote AA, heterozygote AG, and homozygote GG, respectively. Patients with the GG-genotype of the BsmI polymorphic marker of the VDR gene demonstrated lower values of the Charlson comorbidity index (p=0,042), severity of menopausal disorders (p=0,023) and higher quality of life scores for pain intensity that can limit daily activity (p=0,025) compared to patients with AA/AG genotypes. Women homozygous for the minor A allele demonstrated an increase in cognitive abilities according to the MMSE scale (p=0,001) and a decrease in the severity of psychoemotional disorders of the MMI (p=0,027) after the use of standard loading and maintenance doses of cholecalciferol.
Conclusion. A possible protective role of the G allele of the BsmI polymorphic marker of the VDR gene in relation to the Charlson comorbidity index, menopausal disorders, and quality of life in late postmenopausal patients has been demonstrated.
Literature
1. Громова О.А., Торшин И.Ю. Витамин D – смена парадигмы. М.: ГЭОТАР-Медиа. 2021; 736 с. [Gromova O.A., Torshin I.Yu. Vitamin D – a paradigm shift. Moscow: GEOTAR-Media. 2021; 736 pp. (In Russ).]. https://dx.doi.org/10.33029/9704-5787-0-VDPS-2021-1-736. ISBN: 978-5-9704-5787-0. 2. Шварц Г.Я. Дефицит витамина D и его фармакологическая коррекция. Русский медицинский журнал. 2009; 7: 477–486. [Shvarts G.Ya. Vitamin D deficiency and its pharmacological correction. Russkiy meditsinskiy zhurnal = Russian Medical Journal. 2009;7: 477–486 (in Russ.)]. 3. Saponaro F., Saba A., Zucchi R. An update on Vitamin D metabolism. Int J Mol Sci. 2020; 21(18): 6573. https://dx.doi.org/10.3390/ijms21186573. 4. Пигарова Е.А., Рожинская Л.Я., Белая Ж.Е. с соавт. Клинические рекомендации Российской ассоциации эндокринологов по диагностике, лечению и профилактике дефицита витамина D у взрослых. Проблемы эндокринологии. 2016; 4: 60–84. [Pigarova E.A., Rozhinskaya L.Ya., Belaja Zh.E. et al. Russian Association of Endocrinologists recommendations for diagnosis, treatment and prevention of vitamin D deficiency in adults. Problemy endocrinologii = Problems of Endocrinology. 2016; 4: 60–84 (In Russ.)]. https://dx.doi.org/10.14341/probl201662460-84. 5. Christakos S., Dhawan P., Verstuyf A. et al. Vitamin D: Metabolism, molecular mechanism of action, and pleiotropic effects. Physiol Rev. 2016; 96(1):365–408. https://dx.doi.org/10.1152/physrev.00014.2015. 6. Wacker M., Holick M.F. Sunlight and Vitamin D: A global perspective for health. Derm Endocrinol. 2013; 5(1): 51–108. https://dx.doi.org/10.4161/derm.24494. 7. Bouillon R., Marcocci C., Carmeliet G. et al. Skeletal and extraskeletal actions of vitamin D: Current evidence and outstanding questions. Endocr Rev. 2019; 40(4): 1109–51. https://dx.doi.org/10.1210/er.2018-00126. 8. Miyamoto K., Kesterson R.A., Yamamoto H. et al. Structural organization of the human vitamin D receptor chromosomal gene and its promoter. Mol Endocrinol. 1997; 11(8): 1165–79. https://dx.doi.org/10.1210/mend.11.8.9951. 9. Uitterlinden A.G., Fang Y., Van Meurs J.B.J. et al. Genetics and biology of vitamin D receptor polymorphisms. Gene. 2004; 338(2): 143–56. https://dx.doi.org/10.1016/j.gene.2004.05.014. 10. Pike J.W., Meyer M.B. The vitamin D receptor: new paradigms for the regulation of gene expression by 1,25-dihydroxyvitamin D3. Rheum Dis Clin N Am. 2012; 38(1): 13–27. https://dx.doi.org/10.1016/j.rdc.2012.03.004. 11. Valdivielso J.M., Fernandez E. Vitamin D receptor polymorphisms and diseases. Clin Chim Acta. 2006; 371(1–2): 1–12. https://dx.doi.org/10.1016/j.cca.2006.02.016. 12. Charlson M.E., Pompei P., Ales K.L., McKenzie C.R. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chron Dis. 1987; 40(5): 373–83. https://dx.doi.org/10.1016/0021-9681(87)90171-8. 13. Кобалава Ж.Д., Конради А.О., Недогода С.В. с соавт.; Российское кардиологическое общество. Артериальная гипертензия у взрослых. Клинические рекомендации 2020. Российский кардиологический журнал. 2020; 3: 37–86. [Kobalava Zh.D., Konradi A.O., Nedogoda S.V. et al.; Russian society of cardiology. Arterial hypertension in adults. Clinical guidelines 2020. Rossiyskiy kardiologicheskiy zhurnal = Russian Journal of Cardiology. 2020; 3: 37–86 (In Russ.)]. https://dx.doi.org/10.15829/1560-4071-2020-3-3786. 14. Дедов И.И., Шестакова М.В., Майоров А.Ю. с соавт. Алгоритмы специализированной медицинской помощи больным сахарным диабетом: Клинические рекомендации (Вып. 9). Сахарный диабет. 2019; S1: 1–144. [Dedov I.I., Shestakova M.V., Mayorov A.Yu. et al. Standards of specialized diabetes care. Sakharnyy diabet = Diabetes Mellitus. 2019; S1: 1–144 (In Russ.)]. https://dx.doi.org/10.14341/DM221S1. 15. Ревматология. Российские клинические рекомендации. Под ред. Е.Л. Насонова. М.: ГЭОТАР-Медиа. 2017; 456 с. [Rheumatology. Russian clinical guidelines. Ed. by E.L. Nasonov. Moscow: GEOTAR-Media. 2017; 456 pp. (In Russ.)]. ISBN: 978-5-9704-4261-6. 16. Мельниченко Г.А., Белая Ж.Е., Рожинская Л.Я. с соавт. Федеральные клинические рекомендации по диагностике, лечению и профилактике остеопороза. Проблемы эндокринологии. 2017; 6: 392–426. [Melnichenko G.A., Belaya Zh.E., Rozhinskaya L.Ya. et al. Federal clinical recommendations on diagnostics, treatment and prevention of osteoporosis. Problemy endokrinologii = Problems of Endocrinology. 2017; 6: 392–426 (In Russ.)]. https://dx.doi.org/10.14341/probl2017636392-426. 17. Оганов Р.В., Симаненков В. И., Бакулин И. Г. с соавт. Коморбидная патология в клинической практике. Алгоритмы диагностики и лечения. Кардиоваскулярная терапия и профилактика. 2019; 1: 5–66. [Oganov R.V., Simanenkov V.I., Bakulin I.G. et al. Oganov R.G., Simanenkov V.I., Bakulin I.G. et al. Comorbidities in clinical practice. Algorithms for diagnostics and treatment. Kardiovaskulyarnaya terapiya i profilaktika = Cardiovascular Therapy and Prevention. 2019; 1: 5–66 (In Russ.)]. https://dx.doi.org/10.15829/1728-8800-2019-1. 18. Сметник В.П., Ткаченко Н.М., Глезер Г.А., Москаленко Н.П. Климактерический синдром. М.: Медицина. 1988; 288 с. [Smetnik V.P., Tkachenko N.M., Glezer G.A., Moskalenko N.P. Climacteric syndrome. Moscow: Meditsina = Medicine. 1988; 288 pp (In Russ).]. ISBN: 5-225-00198-X. 19. Folstein M.F., Folstein S.E., McHugh P.R. «Mini-mental state». A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975; 12(3): 189–98. https://dx.doi.org/10.1016/0022-3956(75)90026-6. 20. Bjelland I., Dahl A.A., Haug T.T., Neckelmann D. The validity of the Hospital Anxiety and Depression Scale. An updated literature review. J Psychosom Res. 2002; 52(2): 69–77. https://dx.doi.org/10.1016/S0022-3999(01)00296-3. 21. Brazier J.E., Harper R., Jones N.M. et al. Validating the SF-36 health survey questionnaire: new outcome measure for primary care. BMJ. 1992; 305(6846): 160–64. https://dx.doi.org/10.1136/bmj.305.6846.160. 22. Новик А.А., Ионова Т.И. Исследование качества жизни в медицине: учебное пособие. Под ред. Ю.Л. Шевченко. М.: ГЭОТАР-Медиа. 2004; 304 с. [Novik A.A., Ionova T.I. Study of the quality of life in medicine: a textbook. Ed. by Shevchenko Yu.L. Moscow: GEOTAR-Media. 2004; 304 pp. (In Russ.)]. 23. Cashman K.D., Dowling K.G., Skrabakova Z. et al. Vitamin D deficiency in Europe: pandemic? Am J Clin Nutr. 2016; 103(4): 1033–44. https://dx.doi.org/10.3945/ajcn.115.120873. 24. Суплотова Л.А., Авдеева В.А., Пигарова Е.А. с соавт. Первое российское многоцентровое неинтервенционное регистровое исследование по изучению частоты дефицита и недостаточности витамина D в Российской Федерации у взрослых. Терапевтический архив. 2021; 10: 1209–1216. [Suplotova L.A., Avdeeva V.A., Pigarova E.A. et al. The first Russian multicenter non-interventional registry study to study the incidence of vitamin D deficiency and insufficiency in Russian Federation. Terapevticheskiy arkhiv = Therapeutic Archive. 2021; 10: 1209–1216 (In Russ.)]. https://dx.doi.org/10.26442/00403660.2021.10.201071. 25. MacLaughlin J., Holick M.F. Aging decreases the capacity of human skin to produce vitamin D3. J Clin Invest. 1985; 76(4): 1536–38. https://dx.doi.org/10.1172/JCI112134. 26. Caniggia A., Lorè F., di Cairano G., Nuti R. Main endocrine modulators of vitamin D hydroxylases in human pathophysiology. J Steroid Biochem. 1987; 27(4–6): 815–24. https://dx.doi.org/10.1016/0022-4731(87)90154-3. 27. Gilad L.A., Bresler T., Gnainsky J. et al. Regulation of vitamin D receptor expression via estrogen-induced activation of the ERK 1/2 signaling pathway in colon and breast cancer cells. J Endocrinol. 2005; 185(3): 577–92. https://dx.doi.org/10.1677/joe.1.05770. 28. Wortsman J., Matsuoka L.Y., Chen T.C. et al. Decreased bioavailability of vitamin D in obesity [published correction appears in Am J Clin Nutr. 2003 May; 77(5): 1342]. Am J Clin Nutr. 2000; 72(3): 690–93. https://dx.doi.org/10.1093/ajcn/72.3.690. 29. Grober U., Kisters K. Influence of drugs on vitamin D and calcium metabolism. Dermatoendocrinol. 2012; 4(2): 158–66. https://dx.doi.org/10.4161/derm.20731. 30. Волков А.Н., Цуркан Е.В. Популяционно-генетическое исследование полиморфизма гена VDR. Фундаментальная и клиническая медицина. 2019; 2: 72–77. [Volkov A.N., Curkan E.V. Population-genetic research of the VDR gene polymorphism. Fundamental’naya i klinicheskaya meditsina = Fundamental and Clinical Medicine. 2019; 2: 72–77 (In Russ.)]. https://dx.doi.org/10.23946/2500-0764-2019-4-2-72-77. 31. Майлян Э.А. Влияние полиморфизма 283 A>G (BsmI) гена рецептора витамина D на развитие остеопороза у женщин в постменопаузе. Медицинский вестник Юга России. 2016; 4: 32–38. [Maylyan E.A. The influence of vitamin D receptor gen 283 A>G (Bsmi) polymorphism on osteoporosis in postmenopausal women. Meditsinskiy vestnik yuga Rossii = Medical Herald of the South of Russia. 2016; 4: 32–38 (In Russ.)]. https://dx.doi.org/10.21886/2219-8075-2016-4-32-38. 32. Янковская Л.В., Аксенова Е.А., Снежицкий В.А. с соавт. Сравнительный анализ частот генотипов гена рецептора витамина D в белорусской популяции и у пациентов с сердечно-сосудистыми заболеваниями Гродненского региона. Журнал Гродненского государственного медицинского университета. 2017; 3: 338–343. [Yankovskaja L.V., Aksenova E.A., Snezhitskiy V.A. et al. Comparative analysis of the frequencies of genotypes of the vitamin D receptor gene in the Belarusian population and in patients with cardiovascular diseases in the Grodno region. Zhurnal Grodnenskogo gosudarstvennogo meditsinskogo universiteta = Journal of Grodno State Medical University. 2017; 3: 338–343 (In Russ.)]. https://dx.doi.org/10.25298/2221-8785-2017-15-3-338-343. 33. Colombini A., Brayda-Bruno M., Lombardi G. et al. BsmI, Apal and TaqI polymorphisms in the vitamin D receptor gene (VDR) and association with lumbar spine pathologies: An Italian case-control study. PLoS One. 2016; 11(5): e0155004. https://dx.doi.org/10.1371/journal.pone.0155004. 34. Bretherton-Watt D., Given-Wilson R., Mansi J.L. et al. Vitamin D receptor gene polymorphisms are associated with breast cancer risk in a UK Caucasian population. Br J Cancer. 2001; 85(2):171–75. https://dx.doi.org/10.1054/bjoc.2001.1864. 35. Каронова Т. Л., Беляева О.Д., Быстрова А.А. с соавт. Полиморфизмы BsmI, ApaI, TaqI и FokI гена рецептора витамина D и показатели липидного спектра крови у женщин позднего репродуктивного возраста. Артериальная гипертензия. 2019; 5: 557–567. [Karonova T.L., Belyaeva O.D., Bystrova A.A. et al. Lipids profile in vitamin D insufficient/deficient subjects with different genotypes of vitamin D receptor gene. Arterial’naya gipertenziya = Arterial Hypertension. 2019; 5: 557–567 (In Russ.)]. https://dx.doi.org/10.18705/1607-419X-2019-25-5-557-567. 36. Тагиева A.H., Сметник В.П., Сухих Г.Т. с соавт. Изучение роли генов рецептора витамина D (VDR), а-рецептора эстрогенов (ESRa) и a-1-цепи коллагена 1-го типа (COLIAI) в заболеваемости остеопорозом у женщин в постменопаузе. Медицинская генетика. 2005; 2: 90–95. [Tagieva A.H., Smetnik V.P., Sukhikh G.T. et al. Studying the role of genes of receptor vitamin D (VDR), estrogen receptor A (ESRA) and AL collagen 1 (COLIA1) in the development of postmenopausal osteoporosis. Meditsinskaya genetika = Medical Genetics. 2005; 2: 90–95 (In Russ.)]. 37. Козлов А.И., Вершубская Г.Г., Негашева М.А. Полиморфизм гена рецептора витамина D (VDR) в выборках населения европейской России и Приуралья. Пермский медицинский журнал. 2016; 5: 60–66. [Kozlov A.I., Vershubskaja G.G., Negasheva M.A. Polymorphism of vitamin D receptor (VDR) gene in sampling of European Russia and Priuraliye population. Permskiy meditsinskiy zhurnal = Perm Medical Journal. 2016; 5: 60–66 (In Russ.)].
About the Autors
Nadezhda V. Izmozherova, Dr. med. habil., associate professor, head of the Department of pharmacology and clinical pharmacology, Ural State Medical University of the Ministry of Healthcare of Russia. Adress: 620028, Yekaterinburg, 3 Repina Str. E-mail: nadezhda_izm@mail.ru. ORCID: https://orcid.org/0000-0001-7826-9657
Artem A. Popov, Dr. med. habil., associate professor, head of the Department of hospital therapy and emergency medicine, Ural State Medical University of the Ministry of Healthcare of Russia. Adress: 620028, Yekaterinburg,
3 Repina Str. E-mail: art_popov@mail.ru. ORCID: https://orcid.org/0000-0001-6216-2468
Alla V. Ryabinina, chief physician of the clinic of Institute of High Temperature Electrochemistry of the Ural Branch of the Russian Academy of Sciences. Address: 620990, г. Yekaterinburg, 20 Akademicheskaya Str. E-mail: Uroran1@sky.ru. ORCID: https://orcid.org/0000-0003-1536-8126
Anna A. Vikhareva, assistant at the Department of pharmacology and clinical pharmacology, Ural State Medical University of the Ministry of Healthcare of Russia. Adress: 620028, Yekaterinburg, 3 Repina Str. E-mail: anna1993vi@gmail.com. ORCID: https://orcid.org/0000-0002-5951-2110
Elena A. Safianik, senior lecturer of the Department of pharmacology and clinical pharmacology, Ural State Medical University of the Ministry of Healthcare of Russia. Adress: 620028, Yekaterinburg, 3 Repina Str. E-mail: gelenochka@yandex.ru. ORCID: https://orcid.org/0000-0002-4565-2366
Alena V. Spevak, postgraduate student of the Department of pharmacology and clinical pharmacology, Ural State Medical University of the Ministry of Healthcare of Russia. Adress: 620028, Yekaterinburg, 3 Repina Str.
E-mail: docspevak@gmail.com. ORCID: https://orcid.org/0000-0003-1110-6962
Similar Articles
